The OECD has launched an online consultation to get views on how to improve access to innovative therapies, whilst ensuring national drugs budgets do go through the roof.
The consultation, which has the backing of OECD member countries and health ministers of the G7 countries, aims gather experience and ideas, and to identify problems with the current system.
Submissions will be used to develop recommendations for governments of OECD member countries.
Innovative therapies refer to new medicines that bring significant health benefits to patients. The OECD would like answers to the following questions:
- What have been the major changes affecting access to medicines over the past 5 – 10 years?
- What are the top three issues that must be addressed to ensure access to innovative medicines while maintaining financial sustainability of health systems?
- Why are there issues in ensuring access to innovative medicines while maintaining financial sustainability of health systems?
- What changes would improve access to innovative therapies?
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
